Rockwell Medical

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$28,316
$25,832
$22,676
$22,093
Gross Profit
6,239
4,550
3,064
2,870
EBITDA
2,509
1,124
-755
146
EBIT
1,966
575
-1,300
-404
Net Income
1,664
343
-1,731
-1,512
Net Change In Cash
28,316
25,832
22,676
22,093
Free Cash Flow
4,084
1,156
-2,519
-86
Cash
12,338
11,863
6,642
8,983
Basic Shares
32,420
32,033
29,327
28,652

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$83,612
$72,810
$61,931
$62,197
Gross Profit
8,704
4,077
-2,420
2,725
EBITDA
-4,694
-16,167
-27,799
-26,722
EBIT
-6,138
-18,756
-30,314
-29,011
Net Income
-8,439
-20,578
-35,034
-31,932
Net Change In Cash
83,612
72,810
61,931
62,197
Cost of Revenue
36,887
Free Cash Flow
-9,696
-17,695
-34,056
-30,687
Cash
8,983
21,492
13,280
48,682
Basic Shares
23,322
9,866
8,526
6,874

Earnings Calls

Quarter EPS
2024-09-30
$0.04
2024-06-30
$0.01
2024-03-31
-$0.06
2023-12-31
-$0.05